Kind Pharmaceuticals Llc

This study tests an oral drug called AND017 in 64 adults with β-thalassemia, a blood disorder that often requires lifelong transfusions. Participants receive either AND017 or a placebo alongside standard care. The goal is to see if the drug safely raises hemoglobin levels and red…

This early-phase study tests a new drug called AND019 in postmenopausal women with a specific type of advanced breast cancer (ER-positive, HER2-negative) that has not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if …

This study tests a new medicine called AND017 for anemia caused by chronic kidney disease. It is for people with stage 3, 4, or 5 kidney disease who are not yet on dialysis. The study compares AND017 to standard anemia treatments to see if it can safely maintain healthy red blood…

This study tests a new drug called AND017 for anemia in people with a type of bone marrow disorder called lower-risk myelodysplastic syndromes (MDS). The goal is to see if the drug can raise hemoglobin levels or reduce the need for blood transfusions. About 63 participants will r…